Works matching IS 11096535 AND DT 2023 AND VI 20 AND IP 6
Results: 11
SUV39H1 Expression as a Guideline for Omitting Radiotherapy in Lymph Node-positive Triple-negative Breast Cancer Patients.
- Published in:
- Cancer Genomics & Proteomics (1109-6535), 2023, v. 20, n. 6, p. 582, doi. 10.21873/cgp.20407
- By:
- Publication type:
- Article
Clinicopathological and Prognostic Values of Telomerase Reverse Transcriptase (TERT) Promoter Mutations in Ovarian Clear Cell Carcinoma for Predicting Tumor Recurrence, Platinum Resistance and Survival.
- Published in:
- Cancer Genomics & Proteomics (1109-6535), 2023, v. 20, n. 6, p. 626, doi. 10.21873/cgp.20411
- By:
- Publication type:
- Article
Risk Stratification by Tissue GAD1 Expression Level in Curatively Resected Esophageal Squamous Cell Carcinoma.
- Published in:
- Cancer Genomics & Proteomics (1109-6535), 2023, v. 20, n. 6, p. 617, doi. 10.21873/cgp.20410
- By:
- Publication type:
- Article
Potential Common Molecular Mechanisms Between Periodontitis and Hepatocellular Carcinoma: A Bioinformatic Analysis and Validation.
- Published in:
- Cancer Genomics & Proteomics (1109-6535), 2023, v. 20, n. 6, p. 602, doi. 10.21873/cgp.20409
- By:
- Publication type:
- Article
Using Comparative Proteomics to Identify Protein Signatures in Clear Cell Renal Cell Carcinoma.
- Published in:
- Cancer Genomics & Proteomics (1109-6535), 2023, v. 20, n. 6, p. 592, doi. 10.21873/cgp.20408
- By:
- Publication type:
- Article
Hsa_circ_0079557 Promotes the Proliferation of Colorectal Cancer Cells Through the hsa_circ_0079557/miR-502-5p/CCND1 Axis.
- Published in:
- Cancer Genomics & Proteomics (1109-6535), 2023, v. 20, n. 6, p. 567, doi. 10.21873/cgp.20406
- By:
- Publication type:
- Article
Pathogenetic Dichotomy in Angioleiomyoma.
- Published in:
- Cancer Genomics & Proteomics (1109-6535), 2023, v. 20, n. 6, p. 556, doi. 10.21873/cgp.20405
- By:
- Publication type:
- Article
Molecular Characteristics and Therapeutic Vulnerabilities of Claudin-low Breast Cancers Derived from Cell Line Models.
- Published in:
- Cancer Genomics & Proteomics (1109-6535), 2023, v. 20, n. 6, p. 539, doi. 10.21873/cgp.20404
- By:
- Publication type:
- Article
Inhibition of Increased Invasiveness of Breast Cancer Cells With Acquired Tamoxifen Resistance by Suppression of CYR61.
- Published in:
- Cancer Genomics & Proteomics (1109-6535), 2023, v. 20, n. 6, p. 531, doi. 10.21873/cgp.20403
- By:
- Publication type:
- Article
p21 Protein Outperforms Clinico-pathological Criteria in Predicting Liver Metastases in Pancreatic Endocrine Tumors.
- Published in:
- Cancer Genomics & Proteomics (1109-6535), 2023, v. 20, n. 6, p. 522, doi. 10.21873/cgp.20402
- By:
- Publication type:
- Article
Hepatocellular Carcinoma: Up-regulated Circular RNAs Which Mediate Efficacy in Preclinical In Vivo Models.
- Published in:
- Cancer Genomics & Proteomics (1109-6535), 2023, v. 20, n. 6, p. 500, doi. 10.21873/cgp.20401
- By:
- Publication type:
- Article